First of its Kind Pharmaceutical Company Awaits U.S. Federal License to Develop Medicines Derived from THC and CBD

(Desert Hot Springs, California, USA) – Royal Emerald Pharmaceuticals (REP) is poised to receive the first-of-its-kind federal (DEA) license to research, develop and manufacture medicines derived from THC and CBDRoyal Emerald’s mission is to be leaders in the pharmaceutical field by creating non-addictive medicines for veterans, law enforcement and first responders suffering from ailments, such as, PTSD, pain, anxiety, depression, sleep apnea, opiate addiction and other ailments. 

“Our veterans and first responders have paid a tremendous price sacrificing for the betterment of our communitiesI am dedicated to repaying their efforts with the best-in-class medicines to benefit society’s heroes,” said Royal Emerald’s CEO Mark Crozier. 

“’Safe, effective, and non-addictive medicines,’ is the motto that drives our researchWe are currently researching new and safer Active Pharmaceutical Ingredients (APIs) and Botanical Raw Materials (BRMs) that will form the basis of our medicinesOur company seeks only the most current, innovative, and industry-accepted research to ensure our position as a leader in this fast-paced and ever-changing market,” Crozier said. 

REP will provide state-of-the-art medicines and active pharmaceutical ingredients derived from THC and CBD to the Drug Enforcement Agency (DEA) registrants and government agenciesThe company is a private corporation with a federal government license pending approvalOnce granted, REP will be the “first in the nation” to receive this federal approval.

“We adhere to the highest standards and quality measures in our labs to ensure that our products exceed consumer expectationsWe guarantee superior quality medicines by complying with current Good Manufacturing Practices (cGMP) established by the Food and Drug Administration (FDA)Our scientists and team of experts are experienced in drug research and development, ensuring our products are consistent, pure and safe for consumers,” he added. 

Crozier, along with most of the management team, are veterans and retired first responders who understand the everyday struggles these targeted groups face in their line of workCrozier started REP in 2017 to combat the medical issues our veterans and first responders face during and after their service. 

 

For more information, go to www.royalemeraldrx.com or contact Jackie Devereaux, Director of Communications at 619-855-7905 cell or jDevereaux@royalemeraldrx.com  

###

The post First of its Kind Pharmaceutical Company Awaits U.S. Federal License to Develop Medicines Derived from THC and CBD appeared first on CBD Health and Wellness.

Continue Reading First of its Kind Pharmaceutical Company Awaits U.S. Federal License to Develop Medicines Derived from THC and CBD

CBD & Delta-8-THC: What’s the Story?

Even if you are only vaguely familiar with cannabis, chances are you’ve heard of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) at one point or another. As research has progressed, new cannabinoids have been lifted into the spotlight, including delta-8 THC, the sister molecule to delta-9 THC.

Like delta-9, delta-8 is a psychoactive cannabinoid. The point of differentiation between the two compounds largely comes down to potency. While delta-9 can be incredibly strong, delta-8 has a lessened intoxicating effect. Additionally, initial research has supported beneficial medical properties for the treatment of epilepsy and nausea, with less euphoric effects than delta-9.[1, 2]

Within the span of a year, delta-8 has entered into the mind of consumers as a viable alternative to delta-9, which remains classified as a Schedule I substance per the Drug Enforcement Agency (DEA).

But what’s the full story with delta-8?

This question has become an important issue for business owners looking to include delta-8 in their products to meet growing market demand. Currently, the DEA labels synthetically derived delta-8 as illegal.

While delta-8-THC naturally occurs in the cannabis plant, it can also be created from hemp-derived CBD in a process known as isomerization. Thus, delta-8-THC derived from CBD appears to be legal under the current rules laid forth by the 2018 Farm Bill, which removes hemp from the Controlled Substances Act (CSA). The DEA’s Final Interim Rule recognizes the changes made by the 2018 Farm Bill and specifically targets delta-9 THC. However, one can never be too sure in a constantly changing legal landscape.

Since delta-8-THC research is still in its infancy, it remains to be seen how prevalent this up-and-coming cannabinoid will be in future CBD products. There also is the question of whether the government will change its rulings on delta-8-THC.

At this point in time, only time will be the judge of the final outcome of delta-8-THC.

Image Source: Pixabay

Image Credit: https://www.pexels.com/photo/spilled-bottle-of-yellow-capsule-pills-208518/

References

  1. Abrahamov A, et al. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56(23-24):2097-102.
  2. Colasanti BK, et al. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacol Biochem Behav. 1982;16(4):573-578.

The post CBD & Delta-8-THC: What’s the Story? appeared first on CBD Health and Wellness.

Continue Reading CBD & Delta-8-THC: What’s the Story?

CBD & Delta-8-THC: What’s the Story?

Even if you are only vaguely familiar with cannabis, chances are you’ve heard of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) at one point or another. As research has progressed, new cannabinoids have been lifted into the spotlight, including delta-8 THC, the sister molecule to delta-9 THC.

Like delta-9, delta-8 is a psychoactive cannabinoid. The point of differentiation between the two compounds largely comes down to potency. While delta-9 can be incredibly strong, delta-8 has a lessened intoxicating effect. Additionally, initial research has supported beneficial medical properties for the treatment of epilepsy and nausea, with less euphoric effects than delta-9.[1, 2]

Within the span of a year, delta-8 has entered into the mind of consumers as a viable alternative to delta-9, which remains classified as a Schedule I substance per the Drug Enforcement Agency (DEA).

But what’s the full story with delta-8?

This question has become an important issue for business owners looking to include delta-8 in their products to meet growing market demand. Currently, the DEA labels synthetically derived delta-8 as illegal.

While delta-8-THC naturally occurs in the cannabis plant, it can also be created from hemp-derived CBD in a process known as isomerization. Thus, delta-8-THC derived from CBD appears to be legal under the current rules laid forth by the 2018 Farm Bill, which removes hemp from the Controlled Substances Act (CSA). The DEA’s Final Interim Rule recognizes the changes made by the 2018 Farm Bill and specifically targets delta-9 THC. However, one can never be too sure in a constantly changing legal landscape.

Since delta-8-THC research is still in its infancy, it remains to be seen how prevalent this up-and-coming cannabinoid will be in future CBD products. There also is the question of whether the government will change its rulings on delta-8-THC.

At this point in time, only time will be the judge of the final outcome of delta-8-THC.

Image Source: Pixabay

Image Credit: https://www.pexels.com/photo/spilled-bottle-of-yellow-capsule-pills-208518/

References

  1. Abrahamov A, et al. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56(23-24):2097-102.
  2. Colasanti BK, et al. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacol Biochem Behav. 1982;16(4):573-578.

The post CBD & Delta-8-THC: What’s the Story? appeared first on CBD Health and Wellness.

Continue Reading CBD & Delta-8-THC: What’s the Story?

CBD & Delta-8-THC: What’s the Story?

Even if you are only vaguely familiar with cannabis, chances are you’ve heard of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) at one point or another. As research has progressed, new cannabinoids have been lifted into the spotlight, including delta-8 THC, the sister molecule to delta-9 THC.

Like delta-9, delta-8 is a psychoactive cannabinoid. The point of differentiation between the two compounds largely comes down to potency. While delta-9 can be incredibly strong, delta-8 has a lessened intoxicating effect. Additionally, initial research has supported beneficial medical properties for the treatment of epilepsy and nausea, with less euphoric effects than delta-9.[1, 2]

Within the span of a year, delta-8 has entered into the mind of consumers as a viable alternative to delta-9, which remains classified as a Schedule I substance per the Drug Enforcement Agency (DEA).

But what’s the full story with delta-8?

This question has become an important issue for business owners looking to include delta-8 in their products to meet growing market demand. Currently, the DEA labels synthetically derived delta-8 as illegal.

While delta-8-THC naturally occurs in the cannabis plant, it can also be created from hemp-derived CBD in a process known as isomerization. Thus, delta-8-THC derived from CBD appears to be legal under the current rules laid forth by the 2018 Farm Bill, which removes hemp from the Controlled Substances Act (CSA). The DEA’s Final Interim Rule recognizes the changes made by the 2018 Farm Bill and specifically targets delta-9 THC. However, one can never be too sure in a constantly changing legal landscape.

Since delta-8-THC research is still in its infancy, it remains to be seen how prevalent this up-and-coming cannabinoid will be in future CBD products. There also is the question of whether the government will change its rulings on delta-8-THC.

At this point in time, only time will be the judge of the final outcome of delta-8-THC.

Image Source: Pixabay

Image Credit: https://www.pexels.com/photo/spilled-bottle-of-yellow-capsule-pills-208518/

References

  1. Abrahamov A, et al. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56(23-24):2097-102.
  2. Colasanti BK, et al. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacol Biochem Behav. 1982;16(4):573-578.

The post CBD & Delta-8-THC: What’s the Story? appeared first on CBD Health and Wellness.

Continue Reading CBD & Delta-8-THC: What’s the Story?

CBD & Delta-8-THC: What’s the Story?

Even if you are only vaguely familiar with cannabis, chances are you’ve heard of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) at one point or another. As research has progressed, new cannabinoids have been lifted into the spotlight, including delta-8 THC, the sister molecule to delta-9 THC.

Like delta-9, delta-8 is a psychoactive cannabinoid. The point of differentiation between the two compounds largely comes down to potency. While delta-9 can be incredibly strong, delta-8 has a lessened intoxicating effect. Additionally, initial research has supported beneficial medical properties for the treatment of epilepsy and nausea, with less euphoric effects than delta-9.[1, 2]

Within the span of a year, delta-8 has entered into the mind of consumers as a viable alternative to delta-9, which remains classified as a Schedule I substance per the Drug Enforcement Agency (DEA).

But what’s the full story with delta-8?

This question has become an important issue for business owners looking to include delta-8 in their products to meet growing market demand. Currently, the DEA labels synthetically derived delta-8 as illegal.

While delta-8-THC naturally occurs in the cannabis plant, it can also be created from hemp-derived CBD in a process known as isomerization. Thus, delta-8-THC derived from CBD appears to be legal under the current rules laid forth by the 2018 Farm Bill, which removes hemp from the Controlled Substances Act (CSA). The DEA’s Final Interim Rule recognizes the changes made by the 2018 Farm Bill and specifically targets delta-9 THC. However, one can never be too sure in a constantly changing legal landscape.

Since delta-8-THC research is still in its infancy, it remains to be seen how prevalent this up-and-coming cannabinoid will be in future CBD products. There also is the question of whether the government will change its rulings on delta-8-THC.

At this point in time, only time will be the judge of the final outcome of delta-8-THC.

Image Source: Pixabay

Image Credit: https://www.pexels.com/photo/spilled-bottle-of-yellow-capsule-pills-208518/

References

  1. Abrahamov A, et al. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56(23-24):2097-102.
  2. Colasanti BK, et al. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacol Biochem Behav. 1982;16(4):573-578.

The post CBD & Delta-8-THC: What’s the Story? appeared first on CBD Health and Wellness.

Continue Reading CBD & Delta-8-THC: What’s the Story?

CBD & Delta-8-THC: What’s the Story?

Even if you are only vaguely familiar with cannabis, chances are you’ve heard of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) at one point or another. As research has progressed, new cannabinoids have been lifted into the spotlight, including delta-8 THC, the sister molecule to delta-9 THC.

Like delta-9, delta-8 is a psychoactive cannabinoid. The point of differentiation between the two compounds largely comes down to potency. While delta-9 can be incredibly strong, delta-8 has a lessened intoxicating effect. Additionally, initial research has supported beneficial medical properties for the treatment of epilepsy and nausea, with less euphoric effects than delta-9.[1, 2]

Within the span of a year, delta-8 has entered into the mind of consumers as a viable alternative to delta-9, which remains classified as a Schedule I substance per the Drug Enforcement Agency (DEA).

But what’s the full story with delta-8?

This question has become an important issue for business owners looking to include delta-8 in their products to meet growing market demand. Currently, the DEA labels synthetically derived delta-8 as illegal.

While delta-8-THC naturally occurs in the cannabis plant, it can also be created from hemp-derived CBD in a process known as isomerization. Thus, delta-8-THC derived from CBD appears to be legal under the current rules laid forth by the 2018 Farm Bill, which removes hemp from the Controlled Substances Act (CSA). The DEA’s Final Interim Rule recognizes the changes made by the 2018 Farm Bill and specifically targets delta-9 THC. However, one can never be too sure in a constantly changing legal landscape.

Since delta-8-THC research is still in its infancy, it remains to be seen how prevalent this up-and-coming cannabinoid will be in future CBD products. There also is the question of whether the government will change its rulings on delta-8-THC.

At this point in time, only time will be the judge of the final outcome of delta-8-THC.

Image Source: Pixabay

Image Credit: https://www.pexels.com/photo/spilled-bottle-of-yellow-capsule-pills-208518/

References

  1. Abrahamov A, et al. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56(23-24):2097-102.
  2. Colasanti BK, et al. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacol Biochem Behav. 1982;16(4):573-578.

The post CBD & Delta-8-THC: What’s the Story? appeared first on CBD Health and Wellness.

Continue Reading CBD & Delta-8-THC: What’s the Story?

CBD & Delta-8-THC: What’s the Story?

Even if you are only vaguely familiar with cannabis, chances are you’ve heard of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) at one point or another. As research has progressed, new cannabinoids have been lifted into the spotlight, including delta-8 THC, the sister molecule to delta-9 THC.

Like delta-9, delta-8 is a psychoactive cannabinoid. The point of differentiation between the two compounds largely comes down to potency. While delta-9 can be incredibly strong, delta-8 has a lessened intoxicating effect. Additionally, initial research has supported beneficial medical properties for the treatment of epilepsy and nausea, with less euphoric effects than delta-9.[1, 2]

Within the span of a year, delta-8 has entered into the mind of consumers as a viable alternative to delta-9, which remains classified as a Schedule I substance per the Drug Enforcement Agency (DEA).

But what’s the full story with delta-8?

This question has become an important issue for business owners looking to include delta-8 in their products to meet growing market demand. Currently, the DEA labels synthetically derived delta-8 as illegal.

While delta-8-THC naturally occurs in the cannabis plant, it can also be created from hemp-derived CBD in a process known as isomerization. Thus, delta-8-THC derived from CBD appears to be legal under the current rules laid forth by the 2018 Farm Bill, which removes hemp from the Controlled Substances Act (CSA). The DEA’s Final Interim Rule recognizes the changes made by the 2018 Farm Bill and specifically targets delta-9 THC. However, one can never be too sure in a constantly changing legal landscape.

Since delta-8-THC research is still in its infancy, it remains to be seen how prevalent this up-and-coming cannabinoid will be in future CBD products. There also is the question of whether the government will change its rulings on delta-8-THC.

At this point in time, only time will be the judge of the final outcome of delta-8-THC.

Image Source: Pixabay

Image Credit: https://www.pexels.com/photo/spilled-bottle-of-yellow-capsule-pills-208518/

References

  1. Abrahamov A, et al. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56(23-24):2097-102.
  2. Colasanti BK, et al. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacol Biochem Behav. 1982;16(4):573-578.

The post CBD & Delta-8-THC: What’s the Story? appeared first on CBD Health and Wellness.

Continue Reading CBD & Delta-8-THC: What’s the Story?

CBD & Delta-8-THC: What’s the Story?

Even if you are only vaguely familiar with cannabis, chances are you’ve heard of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) at one point or another. As research has progressed, new cannabinoids have been lifted into the spotlight, including delta-8 THC, the sister molecule to delta-9 THC.

Like delta-9, delta-8 is a psychoactive cannabinoid. The point of differentiation between the two compounds largely comes down to potency. While delta-9 can be incredibly strong, delta-8 has a lessened intoxicating effect. Additionally, initial research has supported beneficial medical properties for the treatment of epilepsy and nausea, with less euphoric effects than delta-9.[1, 2]

Within the span of a year, delta-8 has entered into the mind of consumers as a viable alternative to delta-9, which remains classified as a Schedule I substance per the Drug Enforcement Agency (DEA).

But what’s the full story with delta-8?

This question has become an important issue for business owners looking to include delta-8 in their products to meet growing market demand. Currently, the DEA labels synthetically derived delta-8 as illegal.

While delta-8-THC naturally occurs in the cannabis plant, it can also be created from hemp-derived CBD in a process known as isomerization. Thus, delta-8-THC derived from CBD appears to be legal under the current rules laid forth by the 2018 Farm Bill, which removes hemp from the Controlled Substances Act (CSA). The DEA’s Final Interim Rule recognizes the changes made by the 2018 Farm Bill and specifically targets delta-9 THC. However, one can never be too sure in a constantly changing legal landscape.

Since delta-8-THC research is still in its infancy, it remains to be seen how prevalent this up-and-coming cannabinoid will be in future CBD products. There also is the question of whether the government will change its rulings on delta-8-THC.

At this point in time, only time will be the judge of the final outcome of delta-8-THC.

Image Source: Pixabay

Image Credit: https://www.pexels.com/photo/spilled-bottle-of-yellow-capsule-pills-208518/

References

  1. Abrahamov A, et al. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56(23-24):2097-102.
  2. Colasanti BK, et al. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats. Pharmacol Biochem Behav. 1982;16(4):573-578.

The post CBD & Delta-8-THC: What’s the Story? appeared first on CBD Health and Wellness.

Continue Reading CBD & Delta-8-THC: What’s the Story?